The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial - Top-Institutions - MDSpire

The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial

  • By

  • Kai Zhang

  • Run-Qi Guo

  • Shan-Wen Chen

  • Bin Chen

  • Xin-Bo Xue

  • Shan Chen

  • Jian Huang

  • Ming Liu

  • Ye Tian

  • Li Zuo

  • Ming Chen

  • Li-Qun Zhou

  • January 16, 2021

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urology
    • Clinical Research
    • Phytotherapy

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Pain Management
    • Clinical Trials

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Urology
    • Chronic Pain
    • Phytotherapy Research

  • #4

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Urology
    • Clinical Trials
    • Phytotherapy

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Pain Research
    • Clinical Pharmacology

Original Source(s)

The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial

  • by Kai Zhang, Run-Qi Guo, Shan-Wen Chen, Bin Chen, Xin-Bo Xue, Shan Chen, Jian Huang, Ming Liu, Ye Tian, Li Zuo, Ming Chen, Li-Qun Zhou

  • January 16, 2021

Related Content

Robot-assisted laparoscopic nephrectomy: early outcome measures with the implementation of multimodal analgesia and intrathecal morphine via the acute pain service

Benefits of enhanced recovery after surgery in robotic nephrectomy

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

  • by

  • April 6, 2026

  • 3 min